Home » Topics » Regulatory

Regulatory
RSS

NDA filed for intranasal scopolamine during fourth quarter

Jan. 3, 2000

FDA approves Ligand's Targretin Capsules for treatment of CTCL

Dec. 30, 1999

AstraZeneca seeks approval of Atacand HCT in the U.S.

Dec. 30, 1999

Reboxetine + pindolol rapidly relieves symptoms of depression and other CNS disorders

Dec. 30, 1999

Injectable levocarnitine approved for use in dialysis in U.S.

Dec. 28, 1999

FDA clears Taxotere for marketing in NSCLC

Dec. 28, 1999

Celebrex approved by FDA for adjunctive therapy of FAP

Dec. 27, 1999

FDA approves depot form of Genentech's GH, efficacy of other formulations in increasing spine BMD

Dec. 27, 1999

Allergan's therapy for allergic conjunctivitis approved for U.S. marketing

Dec. 27, 1999

Organogenesis seeks FDA approval of Apligraf for diabetic foot ulcers

Dec. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.